Last reviewed · How we verify
ASF 1096 0.5 % cream — Competitive Intelligence Brief
phase 2
Topical corticosteroid
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
ASF 1096 0.5 % cream (ASF 1096 0.5 % cream) — Astion Pharma A/S. ASF 1096 0.5% cream is a topical corticosteroid used to reduce inflammation and itching in various skin conditions.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ASF 1096 0.5 % cream TARGET | ASF 1096 0.5 % cream | Astion Pharma A/S | phase 2 | Topical corticosteroid | ||
| Compound Clobetasol Propionate Ointment | Compound Clobetasol Propionate Ointment | First Hospital of China Medical University | marketed | Topical corticosteroid (Class I/super-potent) | Glucocorticoid receptor | |
| Fluorometholone 0.1% ophthalmic solution | Fluorometholone 0.1% ophthalmic solution | University of Pennsylvania | marketed | Topical corticosteroid | Glucocorticoid receptor | |
| Enstilar® foam | Enstilar® foam | Icahn School of Medicine at Mount Sinai | marketed | Topical corticosteroid + vitamin D analog combination | Glucocorticoid receptor; vitamin D receptor (VDR) | |
| Topical steroid | Topical steroid | University of South Alabama | marketed | Topical corticosteroid | Glucocorticoid receptor | |
| Mometasone furoate 0.1% cream | Mometasone furoate 0.1% cream | Montefiore Medical Center | marketed | Topical corticosteroid | Glucocorticoid receptor | |
| Desoximetasone Spray 0.25% | Desoximetasone Spray 0.25% | Sun Pharmaceutical Industries, Inc. | marketed | Topical corticosteroid | Glucocorticoid receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical corticosteroid class)
- LEO Pharma · 3 drugs in this class
- Pierre Fabre Medicament · 2 drugs in this class
- GlaxoSmithKline · 2 drugs in this class
- Promius Pharma, LLC · 2 drugs in this class
- Astellas Pharma Inc · 1 drug in this class
- Astion Pharma A/S · 1 drug in this class
- Al-Azhar University · 1 drug in this class
- BUZZZ Pharmaceuticals Limited · 1 drug in this class
- Apotex Inc. · 1 drug in this class
- Aswan University Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ASF 1096 0.5 % cream CI watch — RSS
- ASF 1096 0.5 % cream CI watch — Atom
- ASF 1096 0.5 % cream CI watch — JSON
- ASF 1096 0.5 % cream alone — RSS
- Whole Topical corticosteroid class — RSS
Cite this brief
Drug Landscape (2026). ASF 1096 0.5 % cream — Competitive Intelligence Brief. https://druglandscape.com/ci/asf-1096-0-5-cream. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab